UK reviewing Palantir’s NHS contract amid pressure to use break clause
FILE PHOTO: The Palantir logo is seen in this illustration taken August 3, 2025. REUTERS/Dado Ruvic/Illustration/File Photo
Read a summary of this article on FAST.
Get bite-sized news via a new
cards interface. Give it a try.
Click here to return to FAST
Tap here to return to FAST
FAST
LONDON, June 9 : Britain is conducting a full review of its National Health Service contract with U.S. data analytics firm Palantir, amid growing political pressure for the government to use a break clause at the end of the initial term in early 2027.
Technology minister Liz Kendall said on Tuesday the review would assess whether to extend the £330 million ($441 million) deal under provisions allowing the government to continue it for up to seven years or terminate it.
“The current health secretary is reviewing every single aspect of that (contract) to make sure we get the right deal for Britain,” Kendall told Times Radio, referring to concerns about patient confidentiality, public trust and reliance on a U.S. supplier.
The contract, awarded in 2023 to build a platform linking NHS data, runs until early 2027, when the government must decide whether to extend it.
Guess Word
Crack the word, one row at a time
Buzzword
Create words using the given letters
Mini Sudoku
Tiny puzzle, mighty brain teaser
Mini Crossword
Small grid, big challenge
Word Search
Spot as many words as you can
PARLIAMENTARY CRITICISM
A parliamentary committee last week urged ministers to trigger the clause and end the contract, warning Palantir’s role represents an “unacceptable point of weakness” and highlighting risks from relying on a small number of U.S. tech firms.
The committee said the company’s growing role in the public sector raised concerns about dependence on overseas suppliers and the resilience of critical services, while noting officials reported benefits in areas such as waiting list management, operations and hospital discharge planning.
The deal has also drawn scrutiny because Palantir supplies software to the U.S. military and immigration authorities, and over the political views of its billionaire co-founder Peter Thiel, an early supporter of President Donald Trump.
Campaigners and unions have raised concerns about the handling of sensitive health data. Last month, the Financial Times reported NHS officials had proposed granting some external staff, including Palantir personnel, broad administrative access to identifiable patient data on parts of the system.
Palantir has said its software helps improve patient care and efficiency across the NHS.
Neither Palantir nor NHS England immediately responded to requests for comment.
Separately, London Mayor Sadiq Khan last month blocked a £50 million police contract with Palantir, citing concerns about value for money and whether companies’ ethics should be considered in public procurement.
($1 = 0.7486 pounds)
Source: Reuters
Sign up for our newsletters
Get the CNA app
Stay updated with notifications for breaking news and our best stories
Get WhatsApp alerts
Join our channel for the top reads for the day on your preferred chat app
Get bite-sized news via a new
cards interface. Give it a try.
Click here to return to FAST
Tap here to return to FAST
FAST
About The Author
